This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Incidence After the Administration of Blood From Commercial and Volunteer Donor Populations

John H. Walsh, MD; Robert H. Purcell, MD; Andrew G. Morrow, MD; Robert M. Chanock, MD; Paul J. Schmidt, MD

JAMA. 1970;211(2):261-265.

Abstract
The incidence of icteric and anicteric hepatitis was determined prospectively in 110 patients undergoing open-heart operations in which cardiopulmonary bypass was used. Patients were supplied with blood from two commercial blood banks (82 patients), or from local volunteer donors (28 patients). Serial determinations of serum transaminase levels were obtained for six months following operation. Hepatitis developed in 51% (42) of the recipients of commercial blood, but the disease did not occur in any patient who received blood from volunteer donors. The hepatitis carrier rate for commercial blood donors was 6.3%, but, for volunteer donors, was less than 0.6%. This difference in carrier rates probably reflects differences in the donor populations.

Author Affiliations
From the Blood Bank Department, Clinical Center; the Clinic of Surgery, National Heart Institute; and the Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Md; and the National Communicable Disease Center, Atlanta.

Footnotes
Read in part before the American Association of Blood Banks, Washington, DC, Oct 30, 1968.

Reprint requests to Bldg 10A, Room 1E-33, 9000 Rockville Pike, National Institutes of Health, Bethesda, Md 20014 (Dr. Schmidt).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The hazards of blood transfusion in historical perspective
Alter and Klein
Blood 2008;112:2617-2626.
ABSTRACT | FULL TEXT  

History of posttransfusion hepatitis
Tobler and Busch
Clin. Chem. 1997;43:1487-1493.
ABSTRACT | FULL TEXT  

Post-transfusion Hepatitis: Current Perspectives
AACH and KAHN
ANN INTERN MED 1980;92:539-546.
ABSTRACT  

Do Volunteer Donors Decrease Posttransfusion Hepatitis? Study in a Military Donor Population
Holley et al.
JAMA 1975;234:1051-1052.
ABSTRACT  

Radioimmunoassay Detection of Hepatitis Type B Antigen: A Prospective Study in Blood Donors and Recipients
Giorgini et al.
JAMA 1972;222:1514-1518.
ABSTRACT  

Posttransfusion Hepatitis After Exclusion of Commercial and Hepatitis-B Antigen-Positive Donors
ALTER et al.
ANN INTERN MED 1972;77:691-699.
ABSTRACT  

Antibody to Hepatitis-Associated Antigen: Frequency and Pattern of Response as Detected by Radioimmunoprecipitation
Lander et al.
JAMA 1972;220:1079-1082.
ABSTRACT  

Risk of Posttransfusion Hepatitis in the United States: A Prospective Cooperative Study
JAMA 1972;220:692-701.
ABSTRACT  

Australia Antigen and Viral Hepatitis in Drug Abusers
Sutnick et al.
Arch Intern Med 1971;127:939-941.
ABSTRACT  

Commercial Blood in our National Blood Program
Allen
Arch Surg 1971;102:122-126.
ABSTRACT  

Incidence of Posttransfusion Hepatitis in Previously Frozen Blood
Tullis et al.
JAMA 1970;214:719-723.
ABSTRACT